4D Molecular Therapeutics, Inc. — EFFECT Filings
6 EFFECT filings on record
This page lists all EFFECT filings submitted to the SEC by 4D Molecular Therapeutics, Inc. (FDMT), sorted by most recent first. Each row links to the full filing on EdgarLookup. 4D Molecular Therapeutics, Inc. has filed 6 EFFECT documents with the SEC since 2015. To view all SEC filings by 4D Molecular Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
3/A
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
FWP
POS AM
POSASR
RW
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
S-8 POS
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| EFFECT | — | 9999999995-25-000737 | Mar 24, 2025 | — |
| EFFECT | — | 9999999995-23-002401 | Aug 15, 2023 | — |
| EFFECT | — | 9999999995-22-002599 | Sep 6, 2022 | — |
| EFFECT | — | 9999999995-22-000994 | Apr 15, 2022 | — |
| EFFECT | — | 9999999995-21-004087 | Oct 28, 2021 | — |
| EFFECT | — | 9999999995-20-003479 | Dec 10, 2020 | — |